Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2023

  1. Trimethylamine N-Oxide as a Mediator Linking Peripheral to Central Inflammation: An In Vitro Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

2022

  1. Trimethylamine N-oxide (TMAO) drives insulin resistance and cognitive deficiencies in a senescence accelerated mouse model

    Mechanisms of Ageing and Development, Vol. 204

2019

  1. DHA Selectively Protects SAMP-8-Associated Cognitive Deficits Through Inhibition of JNK

    Molecular Neurobiology, Vol. 56, Núm. 3, pp. 1618-1627

2018

  1. Implication of trimethylamine n-oxide (TMAO) in disease: Potential biomarker or new therapeutic target

    Nutrients, Vol. 10, Núm. 10

2017

  1. Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions

    Current Opinion in Pharmacology, Vol. 37, pp. 87-92

  2. Interactions between age, diet, and insulin and their effect on cognition: Implications for alzheimer’s disease

    Role of the Mediterranean Diet in the Brain and Neurodegenerative Diseases (Elsevier), pp. 223-238

2016

  1. Precision Obesity Treatments Including Pharmacogenetic and Nutrigenetic Approaches

    Trends in Pharmacological Sciences, Vol. 37, Núm. 7, pp. 575-593